Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07386587Phase 3Enrolling by invitation
A Phase 3 trial of etanercept in juvenile idiopathic arthritis (JIA), sponsored by University of Child Health Sciences and Children's Hospital, Lahore. Started Jan 2026; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07386587.